Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$2.55
-0.10-3.77%
At close: -
$3.10
0.5521.57%
After Hours: Mar 21, 4:00 PM EDT
Comments
Loading...
CollPlant Biotechnologies Analyst Ratings and Price Targets | NASDAQ:CLGN | Benzinga
CollPlant Biotechnologies Ltd has a consensus price target of $15.44 based on the ratings of 4 analysts. The high is $22.75 issued by Alliance Global Partners on February 17, 2023. The low is $11 issued by HC Wainwright & Co. on November 29, 2024. The 3 most-recent analyst ratings were released by D. Boral Capital on March 27, 2025, February 12, 2025, and February 4, 2025, respectively. With an average price target of $14 between D. Boral Capital, there's an implied 351.61% upside for CollPlant Biotechnologies Ltd from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
D. Boral Capital
HC Wainwright & Co.
EF Hutton
Alliance Global Partners
1calculated from analyst ratings
Analyst Ratings for CollPlant Biotechnologies
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/27/2025 | Buy Now | 351.61% | D. Boral Capital | Jason Kolbert46% | $14 → $14 | Maintains | Buy | Get Alert |
| 02/12/2025 | Buy Now | 351.61% | D. Boral Capital | Jason Kolbert46% | $14 → $14 | Maintains | Buy | Get Alert |
| 02/04/2025 | Buy Now | 351.61% | D. Boral Capital | Jason Kolbert46% | $14 → $14 | Maintains | Buy | Get Alert |
| 11/29/2024 | Buy Now | 254.84% | HC Wainwright & Co. | Swayampakula Ramakanth49% | $11 → $11 | Reiterates | Buy → Buy | Get Alert |
| 11/27/2024 | Buy Now | 351.61% | D. Boral Capital | Jason Kolbert46% | $14 → $14 | Maintains | Buy | Get Alert |
| 08/21/2024 | Buy Now | 254.84% | HC Wainwright & Co. | Swayampakula Ramakanth49% | $11 → $11 | Reiterates | Buy → Buy | Get Alert |
| 08/20/2024 | Buy Now | 351.61% | EF Hutton | Jason Kolbert46% | $14 → $14 | Maintains | Buy | Get Alert |
| 08/05/2024 | Buy Now | 351.61% | EF Hutton | Jason Kolbert46% | → $14 | Initiates | → Buy | Get Alert |
| 05/30/2024 | Buy Now | 254.84% | HC Wainwright & Co. | Swayampakula Ramakanth49% | $11 → $11 | Reiterates | Buy → Buy | Get Alert |
| 04/05/2024 | Buy Now | 254.84% | HC Wainwright & Co. | Swayampakula Ramakanth49% | $11 → $11 | Reiterates | Buy → Buy | Get Alert |
| 11/30/2023 | Buy Now | 254.84% | HC Wainwright & Co. | Swayampakula Ramakanth49% | → $11 | Reiterates | Buy → Buy | Get Alert |
| 08/25/2023 | Buy Now | 254.84% | HC Wainwright & Co. | Swayampakula Ramakanth49% | → $11 | Reiterates | Buy → Buy | Get Alert |
| 03/30/2023 | Buy Now | 254.84% | HC Wainwright & Co. | Swayampakula Ramakanth49% | $26 → $11 | Maintains | Buy | Get Alert |
| 02/17/2023 | Buy Now | 633.87% | Alliance Global Partners | Ben Haynor37% | → $22.75 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for CollPlant Biotechnologies (CLGN) stock?
The latest price target for CollPlant Biotechnologies (NASDAQ:CLGN) was reported by D. Boral Capital on March 27, 2025. The analyst firm set a price target for $14.00 expecting CLGN to rise to within 12 months (a possible 351.61% upside). 10 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for CollPlant Biotechnologies (CLGN)?
The latest analyst rating for CollPlant Biotechnologies (NASDAQ:CLGN) was provided by D. Boral Capital, and CollPlant Biotechnologies maintained their buy rating.
When was the last upgrade for CollPlant Biotechnologies (CLGN)?
There is no last upgrade for CollPlant Biotechnologies
When was the last downgrade for CollPlant Biotechnologies (CLGN)?
There is no last downgrade for CollPlant Biotechnologies.
When is the next analyst rating going to be posted or updated for CollPlant Biotechnologies (CLGN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CollPlant Biotechnologies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CollPlant Biotechnologies was filed on March 27, 2025 so you should expect the next rating to be made available sometime around March 27, 2026.
Is the Analyst Rating CollPlant Biotechnologies (CLGN) correct?
While ratings are subjective and will change, the latest CollPlant Biotechnologies (CLGN) rating was a maintained with a price target of $14.00 to $14.00. The current price CollPlant Biotechnologies (CLGN) is trading at is $3.10, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.